These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34216636)

  • 1. Optimal allocation of limited vaccine to minimize the effective reproduction number.
    Rao IJ; Brandeau ML
    Math Biosci; 2021 Sep; 339():108654. PubMed ID: 34216636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal allocation of limited vaccine to control an infectious disease: Simple analytical conditions.
    Rao IJ; Brandeau ML
    Math Biosci; 2021 Jul; 337():108621. PubMed ID: 33915160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination for communicable endemic diseases: optimal allocation of initial and booster vaccine doses.
    Rao IJ; Brandeau ML
    J Math Biol; 2024 Jun; 89(2):21. PubMed ID: 38926228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationing of Civilian Coronavirus Disease 2019 Vaccines While Supplies Are Limited.
    Zimmerman RK; South-Paul JE; Poland GA
    J Infect Dis; 2020 Nov; 222(11):1776-1779. PubMed ID: 32894861
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
    Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF
    BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity.
    Han S; Cai J; Yang J; Zhang J; Wu Q; Zheng W; Shi H; Ajelli M; Zhou XH; Yu H
    Nat Commun; 2021 Aug; 12(1):4673. PubMed ID: 34344871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy.
    Paltiel AD; Schwartz JL; Zheng A; Walensky RP
    Health Aff (Millwood); 2021 Jan; 40(1):42-52. PubMed ID: 33211536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential allocation of vaccine to control an infectious disease.
    Rao IJ; Brandeau ML
    Math Biosci; 2022 Sep; 351():108879. PubMed ID: 35843382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.
    Miura F; Leung KY; Klinkenberg D; Ainslie KEC; Wallinga J
    PLoS Comput Biol; 2021 Dec; 17(12):e1009697. PubMed ID: 34898617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
    Tuite AR; Zhu L; Fisman DN; Salomon JA
    Ann Intern Med; 2021 Apr; 174(4):570-572. PubMed ID: 33395334
    [No Abstract]   [Full Text] [Related]  

  • 11. The Advisory Committee on Immunization Practices' Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine-United States, 2020.
    McClung N; Chamberland M; Kinlaw K; Matthew DB; Wallace M; Bell BP; Lee GM; Talbot HK; Romero JR; Oliver SE; Dooling K
    Am J Transplant; 2021 Jan; 21(1):420-425. PubMed ID: 33382541
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimal vaccine allocation strategy: Theory and application to the early stage of COVID-19 in Japan.
    Kuniya T; Nakata T; Fujii D
    Math Biosci Eng; 2024 Jun; 21(6):6359-6371. PubMed ID: 39176429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine optimization for COVID-19: Who to vaccinate first?
    Matrajt L; Eaton J; Leung T; Brown ER
    Sci Adv; 2020 Feb; 7(6):. PubMed ID: 33536223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who should be prioritized for COVID-19 vaccination in China? A descriptive study.
    Yang J; Zheng W; Shi H; Yan X; Dong K; You Q; Zhong G; Gong H; Chen Z; Jit M; Viboud C; Ajelli M; Yu H
    BMC Med; 2021 Feb; 19(1):45. PubMed ID: 33563270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment].
    Barrière J; Audigier-Valette C; Borchiellini D; Hoch B; Castelnau O; Francois E; Gastaud L; Skaf R; Berdah JF; Marie W; Lescaut W; Peyrade F; Cluzeau T; Cassuto O; Carles M
    Bull Cancer; 2021 Apr; 108(4):341-342. PubMed ID: 33741139
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of vaccine supplies and delays on optimal control of the COVID-19 pandemic: mapping interventions for the Philippines.
    Estadilla CDS; Uyheng J; de Lara-Tuprio EP; Teng TR; Macalalag JMR; Estuar MRJE
    Infect Dis Poverty; 2021 Aug; 10(1):107. PubMed ID: 34372929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine.
    Kirwin E; Rafferty E; Harback K; Round J; McCabe C
    Pharmacoeconomics; 2021 Sep; 39(9):1059-1073. PubMed ID: 34138458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.
    Buhat CAH; Lutero DSM; Olave YH; Quindala KM; Recreo MGP; Talabis DASJ; Torres MC; Tubay JM; Rabajante JF
    Appl Health Econ Health Policy; 2021 Sep; 19(5):699-708. PubMed ID: 34169485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe mental illness: reassessing COVID-19 vaccine priorities.
    Siva N
    Lancet; 2021 Feb; 397(10275):657. PubMed ID: 33610199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.